{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:14:00Z","timestamp":1794964440174,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS134116"],"award-info":[{"award-number":["R01NS134116"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008222","name":"Ben and Catherine Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA254271"],"award-info":[{"award-number":["R01CA254271"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92019D00018"],"award-info":[{"award-number":["75N92019D00018"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019408","name":"The Marcus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["AC1-07659"],"award-info":[{"award-number":["AC1-07659"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xcrm.2025.102302","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:12:48Z","timestamp":1755245568000},"page":"102302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety"],"prefix":"10.1016","volume":"6","author":[{"given":"Michael E.","family":"Barish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Aftabizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hibbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Suzette","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-3725","authenticated-orcid":false,"given":"Julie R.","family":"Ostberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie R.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishika","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinny","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Arvanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Ressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuthana","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"D\u2019Apuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-8207","authenticated-orcid":false,"given":"Christine E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Badie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102302_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2378543","article-title":"Approved CAR-T therapies have reproducible efficacy and safety in clinical practice","volume":"20","author":"Goyco Vera","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.xcrm.2025.102302_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/WCO.0000000000001318","article-title":"CAR T-cell therapy for gliomas","volume":"37","author":"Song","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.xcrm.2025.102302_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100801","article-title":"Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma","volume":"30","author":"Barish","year":"2022","journal-title":"Neoplasia."},{"key":"10.1016\/j.xcrm.2025.102302_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/noy032","article-title":"CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib8","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3389\/fimmu.2017.01850","article-title":"Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications","volume":"8","author":"Mirzaei","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102302_bib9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102302_bib10","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","article-title":"Cancer cell-intrinsic mechanisms driving acquired immune tolerance","volume":"56","author":"Ghorani","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102302_bib11","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O'Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib13","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.xcrm.2025.102302_bib15","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib16","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib17","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1091581817697685","article-title":"Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent","volume":"36","author":"Parrish-Novak","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.xcrm.2025.102302_bib19","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2174\/138161211798999375","article-title":"In vivo bio-imaging using chlorotoxin-based conjugates","volume":"17","author":"Stroud","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.xcrm.2025.102302_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100830","article-title":"A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients","volume":"23","author":"Yamada","year":"2021","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.xcrm.2025.102302_bib21","doi-asserted-by":"crossref","first-page":"E641","DOI":"10.1093\/neuros\/nyz125","article-title":"Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas","volume":"85","author":"Patil","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.xcrm.2025.102302_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2672","article-title":"Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma","volume":"12","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1078-0432.CCR-22-2038","article-title":"Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed\/Refractory ALL","volume":"29","author":"Aldoss","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib24","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102302_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104998","article-title":"Chlorotoxin binds to both matrix metalloproteinase 2 and neuropilin 1","volume":"299","author":"Farkas","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102302_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jocn.2016.04.012","article-title":"Glioblastoma multiforme targeted therapy: The Chlorotoxin story","volume":"33","author":"Cohen-Inbar","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.xcrm.2025.102302_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102302_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/CJI.0000000000000260","article-title":"Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma","volume":"42","author":"Goff","year":"2019","journal-title":"J. Immunother."},{"key":"10.1016\/j.xcrm.2025.102302_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102302_bib30","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41591-021-01404-8","article-title":"Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis","volume":"27","author":"Vitanza","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102302_bib32","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.xcrm.2025.102302_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00001756-199604100-00013","article-title":"Human astrocytoma cells express a unique chloride current","volume":"7","author":"Ullrich","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.xcrm.2025.102302_bib34","doi-asserted-by":"crossref","first-page":"C1511","DOI":"10.1152\/ajpcell.1996.270.5.C1511","article-title":"Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells","volume":"270","author":"Ullrich","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.xcrm.2025.102302_bib35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.xcrm.2025.102302_bib36","doi-asserted-by":"crossref","first-page":"vi165","DOI":"10.1093\/neuonc\/noab196.649","article-title":"EXTH-10. Exploration of a novel toxin-incorporating CAR T cell: how does chlorotoxin recognize glioblastoma cells?","volume":"23","author":"Aftabizadeh","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2025.102302_bib37","first-page":"39","article-title":"Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide","volume":"30","author":"Jacoby","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib38","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jcp.22296","article-title":"Agents that bind annexin A2 suppress ocular neovascularization","volume":"225","author":"Lima e Silva","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.xcrm.2025.102302_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","article-title":"Biomarkers for cancer-associated fibroblasts","volume":"8","author":"Han","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102302_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12575-023-00196-0","article-title":"Macrophage-Derived MMP-9 and MMP-2 are Closely Related to the Rupture of the Fibrous Capsule of Hepatocellular Carcinoma Leading to Tumor Invasion","volume":"25","author":"Cui","year":"2023","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.xcrm.2025.102302_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010146","article-title":"Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression","volume":"23","author":"Niland","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102302_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102302_bib44","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamcr.2017.05.027","article-title":"Metalloproteinases in extracellular vesicles","volume":"1864","author":"Shimoda","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.xcrm.2025.102302_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144913","article-title":"MMP2 and TLRs modulate immune responses in the tumor microenvironment","volume":"6","author":"Muniz-Bongers","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102302_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/187152811797200696","article-title":"Therapeutic potential of peptide toxins that target ion channels","volume":"10","author":"Beraud","year":"2011","journal-title":"Inflamm. Allergy - Drug Targets"},{"key":"10.1016\/j.xcrm.2025.102302_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mt.2014.208","article-title":"Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy","volume":"23","author":"Jonnalagadda","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102302_bib48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-82-5-1013","article-title":"Analysis of the aphthovirus 2A\/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'","volume":"82","author":"Donnelly","year":"2001","journal-title":"J. Gen. Virol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:43:04Z","timestamp":1762638184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125003751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666379125003751"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102302","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102302"}}